Kainic acid evoked release of D-[3H]aspartate from rat striatum in vitro: characterization and pharmacological modulation
- 1 September 1984
- journal article
- research article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 62 (9) , 1070-1077
- https://doi.org/10.1139/y84-179
Abstract
A presynaptic stimulatory action of kainic acid (KA) on the release of glutamate from corticostriatal neurons is thought to contribute to the toxic effect of KA on cell bodies of neurons in the striatum. To characterize the action of KA on the presynaptic amino acid release, its effect was evaluated on the spontaneous efflux of D-[3H]aspartate (D-[3H]Asp), a marker for glutamatergic neurons, from slices of rat striatum in superfusion experiments. In the concentration range 0.5–10.0 mM, KA significantly increased the spontaneous efflux of D-[3H]Asp. Under similar conditions potassium (K+, 25 mM), veratridine, D-aspartic acid (D-Asp), and N-methyl-D-L-aspartic acid (NMDLA) also induced the efflux of the radiolabelled amino acid. The stimulatory effect of KA, like that of K+, was partly calcium dependent. The action of veratridine, D-Asp, and NMDA was not calcium dependent. Tetrodotoxin (TTX) blocked the action of veratridine on D-[3H]Asp efflux but did not affect the action of KA. In a sodium-free perfusion medium the action of KA was greatly reduced. Dihydrokainic acid produced an effect on D-[3H]Asp efflux comparable in magnitude with that produced by KA. The latter, at a dose of 5 mM, also stimulated the efflux of D-[3H]Asp from the cortex, hippocampus and the septum but its effect on these regions was weaker than its striatal effect. The action of several agents, which previously have been found to depress transmitter release in other systems and (or) to modify the neurotoxic action of KA in vivo, was evaluated on the KA-evoked D-[3H]Asp efflux from striatal slices. Both dopamine and a dopamine receptor agonist, bromocryptine, significantly attenuated this KA-evoked efflux. Other agents (adenosine, atropine, baclofen, carbachol, D-Ala2-D-Leu5-enkephalin, ethanol, flurazepam, γ-aminobutyric acid, glutamate diethyl ester, morphine, and proline) did not modify the stimulatory action of KA on the efflux of D-[3H]Asp. A comparison between the effects of these pharmacological agents on amino acid efflux and their previously reported actions on KA-induced neurotoxicity revealed no obvious association. This observation, as well as a discrepancy between the concentrations of KA affecting transmitter release and exerting a neurotoxic action, suggests that the presynaptic action of KA may not play an important role in its damaging action on striatal neurons.This publication has 35 references indexed in Scilit:
- Perforant path transections protect hippocampal granule cells from kainate lesionNeuroscience Letters, 1978
- Some factors influencing the neurotoxicity of intrastriatal injections of kainic acidNeurochemical Research, 1978
- Evidence for glutamate as a neurotransmitter in the corticofugal fibres to the dorsal lateral geniculate body and the superior colliculus in ratsBrain Research, 1978
- Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analoguesNeuropharmacology, 1978
- Baclofen: effects on amino acid releaseCanadian Journal of Physiology and Pharmacology, 1978
- SODIUM AND POTASSIUM IONS AND ACCUMULATION OF LABELLED d‐ASPARTATE AND GABA IN CRUDE SYNAPTOSOMAL FRACTION FROM RAT CEREBRAL CORTEXJournal of Neurochemistry, 1978
- Aspartic acid and glutamic acid levels in the cochlear nucleus after auditory nerve lesionBrain Research, 1977
- UPTAKE AND METABOLISM OF GLUTAMATE IN ASTROCYTES CULTURED FROM DISSOCIATED MOUSE BRAIN HEMISPHERESJournal of Neurochemistry, 1977
- UPTAKE AND RELEASE OF D‐ AND L‐ASPARTATE BY RAT BRAIN SLICESJournal of Neurochemistry, 1976
- Structural requirements for the inhibition for L-glutamate uptake by glia and nerve endingsBrain Research, 1975